One-carbon metabolism in neurodevelopmental disorders: using broad-based nutraceutics to treat cognitive deficits in complex spectrum disorders.

作者: Laura Schaevitz , Joanne Berger-Sweeney , Laura Ricceri

DOI: 10.1016/J.NEUBIOREV.2014.04.007

关键词:

摘要: Folate and choline, two nutrients involved in the one-carbon metabolic cycle, are intimately regulating DNA integrity, synthesis, biogenic amine methylation. In this review, we discuss evidence that folate choline play an important role normal cognitive development, altered levels of these during periods high neuronal proliferation synaptogenesis can result diminished function. We also use as therapeutic agents a spectrum developmental disorders which intellectual disability is prominent feature, such Fragile-X, Rett syndrome, Down Autism disorders. A survey recent literature suggests nutritional supplements have mild, but generally consistent, effects on improving cognition. Intervening with earlier rather than later development more effective outcomes. Given mild improvements seen after treatments using alone, importance genetic profile parents offspring, suggest nutraceutics early combination other therapeutics likely to positive impacts outcomes broad complex neurodevelopmental

参考文章(179)
Caislin Weathers, Effects of nutritional supplementation on IQ and certain other variables associated with Down syndrome. American journal of mental deficiency. ,vol. 88, pp. 214- 217 ,(1983)
Richard Z. Chen, Schahram Akbarian, Matthew Tudor, Rudolf Jaenisch, Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice Nature Genetics. ,vol. 27, pp. 327- 331 ,(2001) , 10.1038/85906
Jennifer D. Thomas, Nirelia M. Idrus, Bradley R. Monk, Hector D. Dominguez, Prenatal choline supplementation mitigates behavioral alterations associated with prenatal alcohol exposure in rats Birth Defects Research Part A: Clinical and Molecular Teratology. ,vol. 88, pp. 827- 837 ,(2010) , 10.1002/BDRA.20713
Andrea Contestabile, Tatiana Fila, Renata Bartesaghi, Antonio Contestabile, Elisabetta Ciani, Choline acetyltransferase activity at different ages in brain of Ts65Dn mice, an animal model for Down's syndrome and related neurodegenerative diseases Journal of Neurochemistry. ,vol. 97, pp. 515- 526 ,(2006) , 10.1111/J.1471-4159.2006.03769.X
José-Ramón Rueda, Javier Ballesteros, Virginia Guillen, Maria-Isabel Tejada, Ivan Solà, Folic acid for fragile X syndrome. Cochrane Database of Systematic Reviews. ,(2011) , 10.1002/14651858.CD008476.PUB2
Jean-Paul Harpey, Treatment of fragile-X. Pediatrics. ,vol. 69, pp. 670- 670 ,(1982)
Stephen McClelland, Forrest C. Bennett, Clifford J. Sells, Lori Brazee Andrus, Elinor A. Kriegsmann, Vitamin and Mineral Supplementation in Down's Syndrome Pediatrics. ,vol. 72, pp. 707- 713 ,(1983)
Jack S. Krasuski, H. Umesha Shetty, Eileen M. Daly, Stanley I. Rapoport, Mark B. Schapiro, Gene E. Alexander, Wei Huang, High brain myo-inositol levels in the predementia phase of Alzheimer's disease in adults with Down's syndrome: a 1H MRS study. American Journal of Psychiatry. ,vol. 156, pp. 1879- 1886 ,(1999) , 10.1176/AJP.156.12.1879
Véronique Saywell, Angèle Viola, Sylviane Confort-Gouny, Yann Le Fur, Laurent Villard, Patrick J. Cozzone, Brain magnetic resonance study of Mecp2 deletion effects on anatomy and metabolism Biochemical and Biophysical Research Communications. ,vol. 340, pp. 776- 783 ,(2006) , 10.1016/J.BBRC.2005.12.080
Farah D. Lubin, Swati Gupta, R. Ryley Parrish, Nicola M. Grissom, Robin L. Davis, Epigenetic Mechanisms: Critical Contributors to Long-Term Memory Formation The Neuroscientist. ,vol. 17, pp. 616- 632 ,(2011) , 10.1177/1073858410386967